US FDA Bids Adieu To Allergenic Products Adcomm; Vaccines Panel To Take Over Duties

 
• By Sue Sutter

The effort and expense to maintain the committee, which met only 10 days in the past 15 years, can no longer be justified, the FDA said. The terminated panel’s responsibilities will be integrated into the Vaccines and Related Biological Products Advisory Committee.

Allergy testing
Responsibility for allergen testing agents and treatments will shift to the FDA's vaccines panel. • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers